Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?

BJU International

Volumn 109, Issue 10, 2012, Pages 1520-1524

  Punnen, Sanoj ^a   Cooperberg, Matthew R ^a   Sadetsky, Natalia ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CaPSURE; phosphodiesterase inhibitors; radical prostatectomy; sexual bother

Indexed keywords

PHOSPHODIESTERASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG USE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL BOTHER; SEXUAL FUNCTION;

AGED; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; UNITED STATES;

EID: 84860323201     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10605.x     Document Type: Article

References (24)

1. Desireddi NV, Roehl KA, Loeb S, et al,. Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era. Urology 2007; 70: 950-5
2. Bianco FJ Jr, Scardino PT, Eastham JA,. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ('trifecta'). Urology 2005; 66 (Suppl.): 83-94
3. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM,. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999; 54: 503-8
4. Litwin MS, Hays RD, Fink A, et al,. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35
5. Noldus J, Michl U, Graefen M, Haese A, Hammerer P, Huland H,. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur Urol 2002; 42: 118-24
6. Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS,. Correlates of bother following treatment for clinically localized prostate cancer. J Urol 2010; 184: 1309-15
7. Dalkin BL, Christopher BA,. Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments. Urol Oncol 2008; 26: 281-5
8. Muller A, Parker M, Waters BW, Flanigan RC, Mulhall JP,. Penile rehabilitation following radical prostatectomy: predicting success. J Sex Med 2009; 6: 2806-12
9. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90
10. Le JD, Cooperberg MR, Sadetsky N, et al,. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int 2010; 106: 1022-9
11. Nelson CJ, Deveci S, Stasi J, Scardino PT, Mulhall JP,. Sexual bother following radical prostatectomysm. J Sex Med 2010; 7 (Pt 1): 129-35
12. Cooperberg MR, Koppie TM, Lubeck DP, et al,. How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE. Urology 2003; 62: 190-6
13. Prasad MM, Prasad SM, Hevelone ND, et al,. Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer. J Sex Med 2010; 7: 1062-73
14. Bergman J, Gore JL, Penson DF, Kwan L, Litwin MS,. Erectile aid use by men treated for localized prostate cancer. J Urol 2009; 182: 649-54
15. Namiki S, Kwan L, Kagawa-Singer M, Arai Y, Litwin MS,. The effect of erectile function on the use of phosphodiesterase-5 inhibitors after radical prostatectomy in Japanese and U.S. men. Urology 2008; 71: 901-5
16. Lubeck DP, Litwin MS, Henning JM, et al,. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773-7
17. Bergman J, Saigal CS, Kwan L, Litwin MS,. Responsiveness of the University of California-Los Angeles Prostate Cancer Index. Urology 2010; 75: 1418-23
18. Karakiewicz PI, Kattan MW, Tanguay S, et al,. Cross-cultural validation of the UCLA prostate cancer index. Urology 2003; 61: 302-7
19. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH,. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002-12
20. D'Amico AV, Whittington R, Malkowicz SB, et al,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74
21. Montorsi F, Brock G, Lee J, et al,. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54: 924-31
22. Wright JL, Lin DW, Cowan JE, Carroll PR, Litwin MS,. Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis 2008; 11: 67-73
23. Gacci M, Simonato A, Masieri L, et al,. Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy. Health Qual Life Outcomes 2009; 7: 94
24. Knight SJ, Latini DM, Hart SL, et al,. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer 2007; 109: 1769-76